Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
05/13/1998 | EP0841398A2 Kojibiose Phosphorylase, its preparation and use |
05/13/1998 | EP0841397A2 Trehalose phosphorylase, its preparation and uses |
05/13/1998 | EP0841396A1 Human telomerase catalytic subunit |
05/13/1998 | EP0841395A1 Process for producing l-lysine |
05/13/1998 | EP0841394A2 Staphylococcus aureus polynucleotides, polypeptides and their uses |
05/13/1998 | EP0841393A1 HUMAN GALECTIN-4-LIKE PROTEIN AND cDNA ENCODING THE SAME |
05/13/1998 | EP0841093A2 Container with lid |
05/13/1998 | EP0841068A1 Leukemic cell growth inhibitor containing antisense oligonucleotide derivative against wilms' tumor gene (wt1) |
05/13/1998 | EP0841040A1 Therapeutic intraluminal stents |
05/13/1998 | EP0840804A1 Methods and compositions for analyzing nucleic acid molecules utilizing sizing techniques |
05/13/1998 | EP0840802A2 Method of sequencing by oligomer hybridisation |
05/13/1998 | EP0840801A2 Methods and compositions for identifying morphogen analogs |
05/13/1998 | EP0840797A1 Methods and means for targeted gene delivery |
05/13/1998 | EP0840796A2 Mucosal delivery of polynucleotides |
05/13/1998 | EP0840795A1 Helper virus-free herpesvirus vector packaging system |
05/13/1998 | EP0840793A2 An expression control sequence for general and effective expression of genes in plants |
05/13/1998 | EP0840792A2 (s)-hydroxynitrillyase from hevea brasiliensis |
05/13/1998 | EP0840791A2 Generation of immune responses to prostate-specific antigen (psa) |
05/13/1998 | EP0840790A1 Process for the modification of toxic and/or off-flavoured compounds |
05/13/1998 | EP0840789A2 Transketolase-related protein |
05/13/1998 | EP0840788A1 Novel serpin derived from human hypothalamus |
05/13/1998 | EP0840787A2 A human edg-2 receptor homolog |
05/13/1998 | EP0840786A1 Gdu, a novel signalling protein |
05/13/1998 | EP0840785A1 A novel form of dipeptidylpeptidase iv (cd26) found in human serum, antibodies thereto, and uses therefor |
05/13/1998 | EP0840784A1 Method of producing and purifying enzymes |
05/13/1998 | EP0840782A1 Pap mutants that exhibit anti-viral and/or anti-fungal activity in plants |
05/13/1998 | EP0840751A1 Monoclonal antibody capable of binding to pna/nucleic acid complexes |
05/13/1998 | EP0840748A1 Transforming growth factor beta crystals |
05/13/1998 | EP0840747A1 Papillomavirus polyprotein constructs |
05/13/1998 | EP0840744A1 Phosphonic acid-based cationic lipids |
05/13/1998 | EP0840743A1 Therapeutic oligonucleotides targeting the human mdr1 and mrp genes |
05/13/1998 | EP0840742A1 Systematic evolution of ligands by exponential enrichment: chemi-selex |
05/13/1998 | EP0840741A1 Pna-dna chimeras and pna synthons for their preparation |
05/13/1998 | EP0840739A1 High affinity nucleic acid ligands to lectins |
05/13/1998 | EP0840622A1 Adeno-associated viral liposomes and their use in transfecting dendritic cells to stimulate specific immunity |
05/13/1998 | EP0840620A1 Il-8 antagonists for treatment of inflammatory disorders and asthma |
05/13/1998 | EP0840616A1 Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies, as therapeutic agents for the treatment of immunological disease |
05/13/1998 | EP0733062B1 Protecting nucleic acids and methods of analysis |
05/13/1998 | EP0726963A4 -i(CHLAMYDIAE) PROBES FOR USE IN SOLUTION PHASE SANDWICH HYBRIDIZATION ASSAYS |
05/13/1998 | EP0726962A4 Hiv probes for use in solution phase sandwich hybridization assays |
05/13/1998 | EP0696325B1 A method for screening for the presence of a genetic defect associated with thrombosis and/or poor anticoagulant response to activated protein c |
05/13/1998 | EP0651813B1 A brassica regulatory sequence for root-specific or root-abundant gene expression |
05/13/1998 | EP0606376B1 Method for genetically modifying bone marrow cells of primates, and useful cells therefor that produce recombinant retroviral vectors |
05/13/1998 | EP0573614B1 Attenuated, genetically-engineered pseudorabies virus s-prv-155 and uses thereof |
05/13/1998 | EP0406286B1 Dna encoding a ryegrass pollen allergen |
05/13/1998 | EP0375736B1 Nucleic acid fragments encoding mannose binding fragments of human mannose binding protein |
05/13/1998 | CN1181784A Genes encoding lymphocyte interferon regulatory factor (LSIRF) polypeptides |
05/13/1998 | CN1181783A Medical composition |
05/13/1998 | CN1181761A Antigen compsn. against mycoplasma |
05/13/1998 | CN1181759A Process for the purification of glycoproteins like erythropoietin |
05/13/1998 | CN1181720A Remotely programmable matrices with memories and uses thereof |
05/13/1998 | CN1181706A Arteriovenous and venous graft treatments: methods and compsns. |
05/13/1998 | CN1181704A Use of glial neurotrophic factor (GDND) for treatment of hearing disorders |
05/13/1998 | CN1181422A Gene transfer carrier structured by polypeptide in conjunction with growth factor receptor |
05/13/1998 | CN1181421A Gene sequence of fibrin ferment of Agkistrodon acutus snakes |
05/13/1998 | CN1181420A Relative gene of hypertension |
05/12/1998 | US5750876 Isoamylase gene, compositions containing it, and methods of using isoamylases |
05/12/1998 | US5750875 Glycogen biosynthetic enzymes in plants |
05/12/1998 | US5750874 Plant cells that disable fungal infections in transgenic plants |
05/12/1998 | US5750873 Nucleic acid molecules that encode tassel seed 2(TS2), a protein involved in the control of flower development in plants |
05/12/1998 | US5750872 Nucleic acids encoding ascorbate free radial reductase and their uses |
05/12/1998 | US5750871 Transformation and foreign gene expression in Brassica species |
05/12/1998 | US5750870 Plant genetic transformation methods and transgenic plants |
05/12/1998 | US5750869 Soluble solids modification using sucrose phosphate synthase encoding sequences |
05/12/1998 | US5750868 Using a dna adenine methylating gene as a dominant negative gene and a promoter to reverse male sterility in maize |
05/12/1998 | US5750867 Maintenance of male-sterile plants |
05/12/1998 | US5750866 Acetohydroxy acid synthetase |
05/12/1998 | US5750865 Process for modifying the production of carotenoids in plants, and DNA, constructs and cells therefor |
05/12/1998 | US5750864 Delaying wound-induced ripening of fruit |
05/12/1998 | US5750862 Control of plant cell proliferation and growth |
05/12/1998 | US5750848 DNA sequence useful for the production of polyhydroxyalkanoates |
05/12/1998 | US5750826 Bradykinin B2 receptor modified transgenic non-human animals |
05/12/1998 | US5750825 Research on heart disease |
05/12/1998 | US5750692 Alkylating cyano-1-(3,5-di-o-p-toluoyl-beta-d-pentose)imidazole in base, ammonolyating, cyclizing |
05/12/1998 | US5750671 Method for isolating DNA from biological cells |
05/12/1998 | US5750669 Nuclease-stable antiviral agents which can suppress synthesis of antigens and gene expression of proteins |
05/12/1998 | US5750667 System to detect protein-RNA interactions |
05/12/1998 | US5750654 Leukaemia inhibitory factor |
05/12/1998 | US5750651 Cartilage and bone-inducing proteins |
05/12/1998 | US5750571 Methods and therapeutic compositions for treating cystic fibrosis |
05/12/1998 | US5750504 Plant extracts |
05/12/1998 | US5750502 Cloning, expression and uses of a secreted protein, F-spondin |
05/12/1998 | US5750497 Water solublity |
05/12/1998 | US5750481 Soaps produced from high laurate canola oil-based fatty acids |
05/12/1998 | US5750400 Coding sequences of the human BRCA1 gene |
05/12/1998 | US5750399 Isoflavone reductase promoter |
05/12/1998 | US5750398 Vector, element and method for inhibiting immune recognition |
05/12/1998 | US5750396 Stable virus packaging cell lines |
05/12/1998 | US5750395 DNA encoding MAGE-1 C-terminal cytotoxic t lymphocyte immunogenic peptides |
05/12/1998 | US5750394 Identification and use of antiviral compounds that inhibit interaction of host cell proteins and viral proteins required for viral replication |
05/12/1998 | US5750391 Filariid nematode cysteine protease proteins |
05/12/1998 | US5750390 Method and reagent for treatment of diseases caused by expression of the bcl-2 gene |
05/12/1998 | US5750388 Purified scytalidium laccases and nucleic acids encoding same |
05/12/1998 | US5750387 DNA encoing leucyl TRNA synthetase from staphylococcus aureus |
05/12/1998 | US5750386 Pathogen resistant |
05/12/1998 | US5750385 Methods and compositions for regulated transcription and expression of heterologous genes |
05/12/1998 | US5750384 L5 shuttle phasmids |
05/12/1998 | US5750383 Mutation |
05/12/1998 | US5750380 DNA polymerase mediated synthesis of double stranded nucleic acids |
05/12/1998 | US5750377 Process for preparing mammalian T cell growth factor P40 |